MUPOSTARINE can cause fetal harm when administered to pregnant women. It is contraindicated in women who are or may become pregnant. If the patient becomes pregnant while taking the drug, she should be apprised of the potential hazard to the fetus.

Special Precautions

SARMs may cause suppression of clotting factors II, V, VII and X, and an increase in prothrombin time. Hemoglobin and hematocrit should be checked periodically for polycythemia in patients who are receiving high doses of SARMs.